156 related articles for article (PubMed ID: 27208805)
1. Frequency of the CCR5-delta32 allele in Brazilian populations: A systematic literature review and meta-analysis.
Silva-Carvalho WH; de Moura RR; Coelho AV; Crovella S; Guimarães RL
Infect Genet Evol; 2016 Sep; 43():101-7. PubMed ID: 27208805
[TBL] [Abstract][Full Text] [Related]
2. Relationship between chemokine receptor 5 Δ32/W gene polymorphism and lupus nephritis.
Zhou TB; Jiang ZP; Zhou JF; Su N
Hum Immunol; 2014 Sep; 75(9):968-72. PubMed ID: 25167769
[TBL] [Abstract][Full Text] [Related]
3. Association between the chemokine receptor 5 delta32 polymorphism and rheumatoid arthritis: a meta-analysis.
Lee YH; Bae SC; Song GG
Mod Rheumatol; 2013 Mar; 23(2):304-10. PubMed ID: 22638733
[TBL] [Abstract][Full Text] [Related]
4. A Meta-analysis of the relation between chemokine receptor 5 delta32 polymorphism and multiple sclerosis susceptibility.
Song GG; Lee YH
Immunol Invest; 2014; 43(4):299-311. PubMed ID: 24295368
[TBL] [Abstract][Full Text] [Related]
5. CC chemokine receptor 5 Δ32 polymorphism: association analysis and allele distribution among cutaneous leishmaniasis patients from Pakistan.
Sophie M; Hameed A; Muneer A; Samdani AJ; Saleem S; Azhar A
J Cutan Pathol; 2016 Jul; 43(7):564-70. PubMed ID: 26970327
[TBL] [Abstract][Full Text] [Related]
6. Frequency of CCR5-Delta32 deletion in human immunodeficiency virus type 1 (HIV-1) in healthy blood donors, HIV-1-exposed seronegative and HIV-1-seropositive individuals of southern Brazilian population.
Reiche EM; Ehara Watanabe MA; Bonametti AM; Morimoto HK; Akira Morimoto A; Wiechmann SL; Matsuo T; Carvalho De Oliveira J; Vissoci Reiche F
Int J Mol Med; 2008 Nov; 22(5):669-75. PubMed ID: 18949389
[TBL] [Abstract][Full Text] [Related]
7. Chemokine receptor 5 Δ32 polymorphism and systemic lupus erythematosus, vasculitis, and primary Sjogren's syndrome. Meta-analysis of possible associations.
Lee YH; Kim JH; Song GG
Z Rheumatol; 2014 Nov; 73(9):848-55. PubMed ID: 24599359
[TBL] [Abstract][Full Text] [Related]
8. The chemokine receptor 5 delta32 polymorphism and type 1 diabetes, Behcet's disease, and asthma: a meta-analysis.
Song GG; Kim JH; Lee YH
Immunol Invest; 2014; 43(2):123-36. PubMed ID: 24171669
[TBL] [Abstract][Full Text] [Related]
9. Is the European spatial distribution of the HIV-1-resistant CCR5-Delta32 allele formed by a breakdown of the pathocenosis due to the historical Roman expansion?
Faure E; Royer-Carenzi M
Infect Genet Evol; 2008 Dec; 8(6):864-74. PubMed ID: 18790087
[TBL] [Abstract][Full Text] [Related]
10. Negative association between the chemokine receptor CCR5-Delta32 polymorphism and rheumatoid arthritis: a meta-analysis.
Prahalad S
Genes Immun; 2006 Apr; 7(3):264-8. PubMed ID: 16541097
[TBL] [Abstract][Full Text] [Related]
11. CCR5-Δ32 gene variant frequency in the Turkish Cypriot population.
Fahrioglu U; Ergoren MC; Mocan G
Braz J Microbiol; 2020 Dec; 51(4):1711-1717. PubMed ID: 32734471
[TBL] [Abstract][Full Text] [Related]
12. Association between chemokine receptor 5 delta32 polymorphism and susceptibility to cancer: a meta-analysis.
Lee YH; Song GG
J Recept Signal Transduct Res; 2015; 35(6):509-15. PubMed ID: 25203595
[TBL] [Abstract][Full Text] [Related]
13. Population survey of CCR5 delta32, CCR5 m303, CCR2b 64I, and SDF1 3'A allele frequencies in indigenous Chinese healthy individuals, and in HIV-1-infected and HIV-1-uninfected individuals in HIV-1 risk groups.
Wang FS; Hong WG; Cao Y; Liu MX; Jin L; Hu LP; Wang Z; Feng TJ; Hou J; Zhang B; Shi M; Xu DP; Lei ZY; Wang B; Liu ZD; Ye JJ; Peng L; Qiu Y; Winkler C
J Acquir Immune Defic Syndr; 2003 Feb; 32(2):124-30. PubMed ID: 12571520
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the CC chemokine receptor 5 delta32 polymorphism in a Brazilian population with cutaneous leishmaniasis.
Brajão de Oliveira K; Reiche EM; Kaminami Morimoto H; Pelegrinelli Fungaro MH; Estevão D; Pontello R; Franco Nasser T; Watanabe MA
J Cutan Pathol; 2007 Jan; 34(1):27-32. PubMed ID: 17214851
[TBL] [Abstract][Full Text] [Related]
15. Chemokine receptor 5 (CCR5) deletion polymorphism in North Indian patients with coronary artery disease.
Sharda S; Gilmour A; Harris V; Singh VP; Sinha N; Tewari S; Ramesh V; Agrawal S; Mastana S
Int J Cardiol; 2008 Feb; 124(2):254-8. PubMed ID: 17383752
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of CCR5-Δ32 and CCR2-V64I polymorphisms in a mixed population from northeastern Brazil.
Ferreira-Fernandes H; Santos AC; Motta FJ; Canalle R; Yoshioka FK; Burbano RR; Rey JA; da Silva BB; Pinto GR
Genet Mol Res; 2015 Oct; 14(4):11710-8. PubMed ID: 26436495
[TBL] [Abstract][Full Text] [Related]
17. CCR5-Delta32 genetic polymorphism associated with benign clinical course and magnetic resonance imaging findings in Brazilian patients with multiple sclerosis.
Kaimen-Maciel DR; Reiche EM; Brum Souza DG; Frota Comini ER; Bobroff F; Morimoto HK; Ehara Watanabe MA; Carvalho De Oliveira J; Matsuo T; Lopes J; Donadi EA
Int J Mol Med; 2007 Sep; 20(3):337-44. PubMed ID: 17671738
[TBL] [Abstract][Full Text] [Related]
18. Ancient DNA Investigation of a Medieval German Cemetery Confirms Long-Term Stability of CCR5-Δ32 Allele Frequencies in Central Europe.
Bouwman A; Shved N; Akgül G; Rühli F; Warinner C
Hum Biol; 2017 Apr; 89(2):119-124. PubMed ID: 29299966
[TBL] [Abstract][Full Text] [Related]
19. CCR5-Δ32 gene variant frequency in the Nigerian and Zimbabwean populations living in North Cyprus.
Ndikom BC; Ergoren MC; Sayan M; Mocan G; Fahrioğlu U
Afr Health Sci; 2022 Mar; 22(1):361-366. PubMed ID: 36032469
[TBL] [Abstract][Full Text] [Related]
20. Chemokine receptor 5 (CCR5) delta 32 polymorphism in lupus nephritis: a large case-control study and meta-analysis.
Cheng FJ; Zhou XJ; Zhao YF; Zhao MH; Zhang H
Autoimmunity; 2014 Sep; 47(6):383-8. PubMed ID: 24720467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
